Lexpos News

Following the latest announcement of an increase in the energy price cap, PSNC has once again called on the Government to provide urgent financial support for community pharmacies. PSNC is extremely concerned about the desperate financial situation that many community pharmacy contractors already find themselves in, and rising energy bills will only make this worse, [...]

The post PSNC calls for urgent support with rising utility bills appeared first on PSNC Website.

PSNC and NHS Digital are encouraging community pharmacy teams to share their views relating to the new NHS Booking and Referral Standard (BaRS). This will ensure that the tool supports the needs of pharmacy team members and their patients. BaRS is an interoperability standard for healthcare IT systems which should enable booking and referral information [...]

The post Support the development of the new NHS Booking and Referral Standard appeared first on PSNC Website.

Class 2 Medicines Recall: Lorazepam 2mg/ml Injection, Lorazepam 4mg/ml Injection (unlicensed medicines) Drug alert number: EL(22)A/37 Date issued: 30 August 2022 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Lorazepam 2mg/ml Injection Unlicensed medicine Batch Number Expiry Date Pack Size First Distributed 070084 31 July 2023 25 [...]

The post Class 2 Medicines Recall: Lorazepam 2mg/ml Injection, Lorazepam 4mg/ml Injection (Hikma Pharmaceuticals USA Inc) appeared first on PSNC Website.

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 September 2022. ADVANCE NOTICE Pharmacy contractors should note that from October 2022, the discount applied to the monthly total of reimbursement prices will be [...]

The post Drug Tariff Watch – September 2022 appeared first on PSNC Website.